Before accepting money, the following is a guide to your due diligence process.
Earlier this year, the CFDA introduced significant changes to the drug and device approval process.
Companies must be aware of the changing clinical trial regulatory environment for devices in China.
In lieu of trials, some companies may be able to submit a CER.
How do the latest requirements affect your business?